J&J SNACK FOODS CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that J&J SNACK FOODS CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Sep 26, 2020 | $1.02B | Nov 25, 2020 |
| FY2020 | Sep 28, 2019 | $1.19B | Nov 25, 2020 |
| FY2018 | Sep 29, 2018 | $300.72M | Nov 28, 2018 |
| FY2018 | Jun 30, 2018 | $306.24M | Nov 28, 2018 |
| FY2018 | Mar 31, 2018 | $266.10M | Nov 28, 2018 |
| FY2018 | Dec 30, 2017 | $265.21M | Nov 28, 2018 |
| FY2018 | Sep 30, 2017 | $316.73M | Nov 28, 2018 |
| FY2018 | Jun 24, 2017 | $295.42M | Nov 28, 2018 |
| FY2018 | Mar 25, 2017 | $246.51M | Nov 28, 2018 |
| FY2018 | Dec 24, 2016 | $225.57M | Nov 28, 2018 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2017 | $316.73M | Nov 28, 2017 |
| FY2017 | Jun 24, 2017 | $295.42M | Nov 28, 2017 |
| FY2017 | Mar 25, 2017 | $246.51M | Nov 28, 2017 |
| FY2017 | Dec 24, 2016 | $225.57M | Nov 28, 2017 |
| FY2017 | Sep 24, 2016 | $262.24M | Nov 28, 2017 |
| FY2017 | Jun 25, 2016 | $277.98M | Nov 28, 2017 |
| FY2017 | Mar 26, 2016 | $229.71M | Nov 28, 2017 |
| FY2017 | Dec 26, 2015 | $222.85M | Nov 28, 2017 |
| FY2016 | Sep 26, 2015 | $259.77M | Nov 22, 2016 |
| FY2016 | Jun 27, 2015 | $278.72M | Nov 22, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $469.88M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $486.13M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $469.87M | Nov 26, 2025 |
| FY2024 | Sep 24, 2022 | $369.64M | Nov 26, 2024 |
| FY2023 | Sep 25, 2021 | $298.93M | Nov 28, 2023 |
| FY2020 | Sep 26, 2020 | $53.93M | Nov 25, 2020 |
| FY2020 | Jun 30, 2020 | $37.20M | Nov 25, 2020 |
| FY2020 | Mar 28, 2020 | $69.44M | Nov 25, 2020 |
| FY2020 | Dec 28, 2019 | $77.86M | Nov 25, 2020 |
| FY2020 | Sep 28, 2019 | $92.94M | Nov 25, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $65.60M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $86.55M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $78.91M | Nov 26, 2025 |
| FY2024 | Sep 24, 2022 | $47.24M | Nov 26, 2024 |
| FY2023 | Sep 25, 2021 | $55.61M | Nov 28, 2023 |
| FY2020 | Sep 26, 2020 | $6.58M | Nov 25, 2020 |
| FY2020 | Jun 30, 2020 | ($12.65M) | Nov 25, 2020 |
| FY2020 | Mar 28, 2020 | $7.31M | Nov 25, 2020 |
| FY2020 | Dec 28, 2019 | $17.06M | Nov 25, 2020 |
| FY2020 | Sep 28, 2019 | $26.07M | Nov 25, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $84.33M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $117.55M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $109.52M | Nov 26, 2025 |
| FY2024 | Sep 24, 2022 | $61.80M | Nov 26, 2024 |
| FY2023 | Sep 25, 2021 | $71.22M | Nov 28, 2023 |
| FY2022 | Sep 26, 2020 | $17.19M | Nov 22, 2022 |
| FY2021 | Sep 28, 2019 | $116.96M | Nov 23, 2021 |
| FY2020 | Sep 29, 2018 | $110.78M | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $118.11M | Nov 27, 2019 |
| FY2018 | Sep 24, 2016 | $112.81M | Nov 28, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $1.40M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $1.20M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $1.20M | Nov 26, 2025 |
| FY2024 | Sep 24, 2022 | $700.0K | Nov 26, 2024 |
| FY2023 | Sep 25, 2021 | $600.0K | Nov 28, 2023 |
| FY2022 | Sep 26, 2020 | $700.0K | Nov 22, 2022 |
| FY2021 | Sep 28, 2019 | $645.0K | Nov 23, 2021 |
| FY2020 | Sep 29, 2018 | $623.0K | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $674.0K | Nov 27, 2019 |
| FY2018 | Sep 24, 2016 | $525.0K | Nov 28, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $165.13M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $173.07M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $172.28M | Nov 26, 2025 |
| FY2024 | Sep 24, 2022 | $26.06M | Nov 26, 2024 |
| FY2023 | Sep 25, 2021 | $101.50M | Nov 28, 2023 |
| FY2022 | Sep 26, 2020 | $92.14M | Nov 22, 2022 |
| FY2021 | Sep 28, 2019 | $147.50M | Nov 23, 2021 |
| FY2020 | Sep 29, 2018 | $123.37M | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $125.35M | Nov 27, 2019 |
| FY2018 | Sep 24, 2016 | $121.23M | Nov 28, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $82.87M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $73.57M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $104.74M | Nov 26, 2025 |
| FY2024 | Sep 24, 2022 | $87.29M | Nov 26, 2024 |
| FY2023 | Sep 25, 2021 | $53.58M | Nov 28, 2023 |
| FY2022 | Sep 26, 2020 | $57.82M | Nov 22, 2022 |
| FY2021 | Sep 28, 2019 | $57.13M | Nov 23, 2021 |
| FY2020 | Sep 29, 2018 | $60.02M | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $72.18M | Nov 27, 2019 |
| FY2018 | Sep 24, 2016 | $48.71M | Nov 28, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $1.38B | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $1.37B | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $1.28B | Nov 26, 2025 |
| FY2024 | Sep 24, 2022 | $1.22B | Nov 26, 2024 |
| FY2023 | Sep 25, 2021 | $1.12B | Nov 28, 2023 |
| FY2022 | Sep 26, 2020 | $1.06B | Nov 22, 2022 |
| FY2021 | Sep 28, 2019 | $1.02B | Nov 23, 2021 |
| FY2020 | Sep 29, 2018 | $938.23M | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | $867.23M | Nov 27, 2019 |
| FY2018 | Sep 24, 2016 | $790.49M | Nov 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $966.70M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $956.97M | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | $911.52M | Nov 26, 2025 |
| FY2025 | Sep 24, 2022 | $863.17M | Nov 26, 2025 |
| FY2024 | Sep 25, 2021 | $845.65M | Nov 26, 2024 |
| FY2023 | Sep 26, 2020 | $809.50M | Nov 28, 2023 |
| FY2022 | Sep 28, 2019 | $833.75M | Nov 22, 2022 |
| FY2021 | Sep 29, 2018 | $759.09M | Nov 23, 2021 |
| FY2020 | Sep 30, 2017 | $682.32M | Nov 25, 2020 |
| FY2019 | Sep 24, 2016 | $637.97M | Nov 27, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $185.07M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $185.07M | Nov 26, 2025 |
| FY2024 | Sep 30, 2023 | $185.07M | Nov 26, 2024 |
| FY2023 | Sep 24, 2022 | $184.42M | Nov 28, 2023 |
| FY2022 | Sep 25, 2021 | $121.83M | Nov 22, 2022 |
| FY2021 | Sep 26, 2020 | $121.83M | Nov 23, 2021 |
| FY2021 | Feb 4, 2020 | $19.32M | Nov 23, 2021 |
| FY2020 | Sep 28, 2019 | $102.51M | Nov 25, 2020 |
| FY2019 | Sep 29, 2018 | $102.51M | Nov 27, 2019 |
| FY2018 | Sep 30, 2017 | $102.51M | Nov 28, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $840.22M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $835.75M | Nov 26, 2025 |
| FY2024 | Sep 30, 2023 | $807.13M | Nov 26, 2024 |
| FY2023 | Sep 24, 2022 | $782.86M | Nov 28, 2023 |
| FY2022 | Sep 25, 2021 | $785.44M | Nov 22, 2022 |
| FY2021 | Sep 26, 2020 | $775.82M | Nov 23, 2021 |
| FY2020 | Sep 28, 2019 | $801.00M | Nov 25, 2020 |
| FY2019 | Sep 29, 2018 | $743.75M | Nov 27, 2019 |
| FY2018 | Sep 30, 2017 | $673.82M | Nov 28, 2018 |
| FY2017 | Sep 24, 2016 | $626.06M | Nov 28, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | $105.89M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | $73.39M | Nov 26, 2025 |
| FY2024 | Sep 30, 2023 | $49.58M | Nov 26, 2024 |
| FY2023 | Sep 24, 2022 | $35.18M | Nov 28, 2023 |
| FY2022 | Sep 25, 2021 | $283.19M | Nov 22, 2022 |
| FY2021 | Sep 26, 2020 | $195.81M | Nov 23, 2021 |
| FY2021 | Sep 28, 2019 | $192.40M | Nov 23, 2021 |
| FY2021 | Sep 29, 2018 | $111.48M | Nov 23, 2021 |
| FY2020 | Sep 30, 2017 | $90.96M | Nov 25, 2020 |
| FY2019 | Sep 24, 2016 | $140.65M | Nov 27, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | 3 | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | 4 | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | 4 | Nov 26, 2025 |
| FY2024 | Sep 24, 2022 | 2 | Nov 26, 2024 |
| FY2023 | Sep 25, 2021 | 2 | Nov 28, 2023 |
| FY2022 | Sep 26, 2020 | 0 | Nov 22, 2022 |
| FY2021 | Sep 28, 2019 | 5 | Nov 23, 2021 |
| FY2020 | Sep 29, 2018 | 5 | Nov 25, 2020 |
| FY2019 | Sep 30, 2017 | 4 | Nov 27, 2019 |
| FY2018 | Sep 24, 2016 | 4 | Nov 28, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | 3 | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | 4 | Nov 26, 2025 |
| FY2025 | Sep 30, 2023 | 4 | Nov 26, 2025 |
| FY2024 | Sep 24, 2022 | 2 | Nov 26, 2024 |
| FY2023 | Sep 25, 2021 | 2 | Nov 28, 2023 |
| FY2020 | Sep 26, 2020 | 0 | Nov 25, 2020 |
| FY2020 | Jun 30, 2020 | 0 | Nov 25, 2020 |
| FY2020 | Mar 28, 2020 | 0 | Nov 25, 2020 |
| FY2020 | Dec 28, 2019 | 0 | Nov 25, 2020 |
| FY2020 | Sep 28, 2019 | 1 | Nov 25, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 27, 2025 | 19.44M | Nov 26, 2025 |
| FY2025 | Sep 28, 2024 | 19.46M | Nov 26, 2025 |
| FY2024 | Sep 30, 2023 | 19.33M | Nov 26, 2024 |
| FY2023 | Sep 24, 2022 | 19.22M | Nov 28, 2023 |
| FY2022 | Sep 25, 2021 | 19.08M | Nov 22, 2022 |
| FY2021 | Sep 26, 2020 | 18.92M | Nov 23, 2021 |
| FY2020 | Sep 28, 2019 | 18.90M | Nov 25, 2020 |
| FY2019 | Sep 29, 2018 | 18.75M | Nov 27, 2019 |
| FY2018 | Sep 30, 2017 | 18.66M | Nov 28, 2018 |
| FY2017 | Sep 24, 2016 | 18.67M | Nov 28, 2017 |